In the present study, we examined the expression status of MLL2 in ESCC patients and found that both mRNA and protein levels of MLL2 exhibited significantly higher expression in tumor tissues than adjacent normal tissues. This evidence concerns the gene KMT2D and esophageal squamous cell carcinoma.